NHC vs. GH, OPCH, RDNT, BTSG, SHC, SGRY, VCYT, LFST, PRVA, and CON
Should you be buying National HealthCare stock or one of its competitors? The main competitors of National HealthCare include Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Surgery Partners (SGRY), Veracyte (VCYT), LifeStance Health Group (LFST), Privia Health Group (PRVA), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.
National HealthCare vs.
Guardant Health (NASDAQ:GH) and National HealthCare (NYSE:NHC) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their community ranking, risk, dividends, profitability, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.
National HealthCare has a net margin of 10.03% compared to Guardant Health's net margin of -74.02%. National HealthCare's return on equity of 6.87% beat Guardant Health's return on equity.
92.6% of Guardant Health shares are held by institutional investors. Comparatively, 56.4% of National HealthCare shares are held by institutional investors. 5.5% of Guardant Health shares are held by insiders. Comparatively, 13.8% of National HealthCare shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.
National HealthCare has higher revenue and earnings than Guardant Health. Guardant Health is trading at a lower price-to-earnings ratio than National HealthCare, indicating that it is currently the more affordable of the two stocks.
Guardant Health has a beta of 1.32, suggesting that its share price is 32% more volatile than the S&P 500. Comparatively, National HealthCare has a beta of 0.45, suggesting that its share price is 55% less volatile than the S&P 500.
Guardant Health presently has a consensus target price of $44.78, suggesting a potential upside of 4.45%. Given Guardant Health's stronger consensus rating and higher possible upside, equities research analysts clearly believe Guardant Health is more favorable than National HealthCare.
In the previous week, Guardant Health had 18 more articles in the media than National HealthCare. MarketBeat recorded 21 mentions for Guardant Health and 3 mentions for National HealthCare. Guardant Health's average media sentiment score of 0.54 beat National HealthCare's score of 0.01 indicating that Guardant Health is being referred to more favorably in the media.
Guardant Health received 286 more outperform votes than National HealthCare when rated by MarketBeat users. However, 100.00% of users gave National HealthCare an outperform vote while only 70.59% of users gave Guardant Health an outperform vote.
Summary
Guardant Health and National HealthCare tied by winning 9 of the 18 factors compared between the two stocks.
Get National HealthCare News Delivered to You Automatically
Sign up to receive the latest news and ratings for NHC and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
National HealthCare Competitors List
Related Companies and Tools
This page (NYSE:NHC) was last updated on 2/22/2025 by MarketBeat.com Staff
Free NHC Stock Alerts